Carle Cancer Center Community Clinical Oncology Program

描述（由申请人提供）：根据RFA-CA-12-007，位于伊利诺伊州厄巴纳市的国家癌症研究所、卡尔癌症中心社区临床肿瘤项目（CCOP）正在申请作为伊利诺伊州中东部CCOP的持续资助。卡尔癌症中心CCOP由一个主要基地和两个组成部分组成，自CCOP于1983年成立以来一直得到资助。Carle现在是一家综合医疗保健组织，汇集了一个研究驱动的医疗保健服务网络。该网络的核心是卡尔基金会医院、卡尔医师集团和健康联盟医疗计划。Carle CCOP拥有325张床位的一级创伤医院，300多名医生团队和自有的健康保险产品，拥有进一步开展研究任务所需的资源。加入Carle CCOP的机构包括伊利诺伊州奥罗拉市的拉什-科普利医疗中心和印第安纳州密歇根市的圣安东尼医疗中心。该流域共有400多万人口，其中130万是少数民族。CCOP的主要研究基地位于伊利诺伊州厄巴纳，所有的注册、随机化、质量保证和数据管理都在这里进行。CCOP的主要研究基地隶属于Alliance。此外，卡尔癌症中心CCOP是东部合作肿瘤小组（ECOG）、国家外科辅助乳房和肠项目（NSABP）、放射治疗肿瘤小组（RTOG）、妇科肿瘤小组（GOG）和癌症试验支持单位（CTSU）的长期成员。此外，今年春天，卡尔癌症中心CCOP加入了太阳海岸CCOP研究基地。Carle CCOP最近经历了一倍的应计率，并充分预计在未来五年内468名治疗对象和703名癌症控制对象的应计率。CCOP拥有一个由12名调查员组成的专门研究小组，50多名工作人员，以及互动的行政支持，为取得成功做好了准备。基于研究驱动的文化，经验丰富和敬业的调查人员，以及无可挑剔的监管标准，Carle CCOP定位于为其服务的社区提供最高水平的护理。

DESCRIPTION (provided by applicant): In response to RFA-CA-12-007, Community Clinical Oncology Program (CCOP), National Cancer Institute, the Carle Cancer Center located in Urbana, Illinois is applying for continued funding as an East Central Illinois CCOP. The Carle Cancer Center CCOP, consisting of a main base and two components, has been continually funded since the inception of the CCOP in 1983. Carle, now an integrated healthcare organization, brings together a research-driven network of healthcare services. At the core of this network reside the Carle Foundation Hospital, Carle Physician Group and Health Alliance Medical Plans. With a 325-bed Level I trauma hospital, over 300 physician group, and a self-owned health insurance product, the Carle CCOP possesses the resources necessary to further its research mission. Joining the Carle CCOP as component institutions are Rush-Copley Medical Center in Aurora, Illinois and Franciscan St. Anthony Health in Michigan City, Indiana. Altogether, the catchment area consists of over 4 million people of which 1.3 million are minorities. The CCOP's primary research base is located in Urbana, Illinois where all registration, randomization, quality assurance, and data management are conducted. The CCOP's primary research base affiliation is with Alliance. Additionally, the Carle Cancer Center CCOP is long-standing members of the Eastern Cooperative Oncology Group (ECOG), the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), the Gynecological Oncology Group (GOG), and the Cancer Trials Support Unit (CTSU). Additionally, this past spring, the Carle Cancer Center CCOP joined the SunCoast CCOP Research Base. The Carle CCOP has recently experienced a doubling of accrual and fully anticipates accrual rates of 468 treatment subjects and 703 cancer control subjects over the next five years. With a dedicated research team of 12 investigators, over 50 staff members, and interactive administrative support, the CCOP is well-positioned to succeed. Based on a research-driven culture, seasoned and engaged investigators, and impeccable regulatory standards, the Carle CCOP is positioned to provide the highest level of care to the communities it serves.